ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 634,74
2,14%
Dow Jones
43 206,56
-0,03%
DAX
20 655,39
0,19%
Brent Oil
80,385
-1,59%
Bitcoin
99 628,43
-0,88%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Genelux Corporation (GNLX)

  7. Genelux Corporation (GNLX) Actualités

GNLX

Genelux (GNLX)

Genelux Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GNLX
DateHeureSourceTitreSymboleSociété
31/12/202419h20Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GNLXGenelux Corporation
31/12/202401h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
30/12/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
13/12/202413h01GlobeNewswire Inc.Genelux Corporation to Participate in a Fireside Chat with H.C. WainwrightNASDAQ:GNLXGenelux Corporation
14/11/202422h05GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
22/10/202422h12Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GNLXGenelux Corporation
22/10/202422h01GlobeNewswire Inc.Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung CancerNASDAQ:GNLXGenelux Corporation
09/10/202422h15GlobeNewswire Inc.Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:GNLXGenelux Corporation
03/10/202423h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
03/09/202422h01GlobeNewswire Inc.Genelux Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:GNLXGenelux Corporation
14/08/202422h05GlobeNewswire Inc.Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
14/08/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
30/07/202413h00GlobeNewswire Inc.Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024NASDAQ:GNLXGenelux Corporation
14/06/202422h20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:GNLXGenelux Corporation
14/06/202422h15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GNLXGenelux Corporation
14/06/202422h10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GNLXGenelux Corporation
24/05/202423h19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
24/05/202414h00GlobeNewswire Inc.Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsNASDAQ:GNLXGenelux Corporation
23/05/202422h01GlobeNewswire Inc.Genelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:GNLXGenelux Corporation
09/05/202422h25GlobeNewswire Inc.Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
01/04/202413h00GlobeNewswire Inc.Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GNLXGenelux Corporation
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GNLXGenelux Corporation
02/02/202422h36Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GNLXGenelux Corporation
02/02/202422h06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GNLXGenelux Corporation
27/11/202313h00GlobeNewswire Inc.Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNASDAQ:GNLXGenelux Corporation
14/11/202323h50GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
19/09/202323h37Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:GNLXGenelux Corporation
14/09/202313h00GlobeNewswire Inc.Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GNLXGenelux Corporation
14/09/202302h13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
28/08/202313h00GlobeNewswire Inc.Genelux Corporation Announces New Chief Financial OfficerNASDAQ:GNLXGenelux Corporation
 Showing the most relevant articles for your search:NASDAQ:GNLX

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
EN
Bouygues
NASDAQ
AAPL
Apple
EU
RI
Pernod Ricard
NYSE
MCD
McDonalds
NYSE
MRK
Merck
EU
BN
Danone
EU
BNP
BNP Paribas
NASDAQ
GOOGL
Alphabet
COIN
DOGEUSD
Dogecoin
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
RNO
Renault
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés